Anemia is a common complication of CKD, typically occurring early in the development of the disease and becoming more severe as CKD progresses. The primary treatment goal in renal anemia is to increase and maintain hemoglobin and other anemia parameters, such as ferritin.
This report contains market size and forecasts of Renal Anemia Treatment in global, including the following market information:
Global Renal Anemia Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Renal Anemia Treatment Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Renal Anemia Treatment companies in 2021 (%)
The global Renal Anemia Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Iron Supplements Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Renal Anemia Treatment include Amgen Inc., F. Hoffmann-La Roche Ltd, Pfizer Inc., Novartis AG, Johnson & Johnson Services Inc., Teva Pharmaceutical Industries Ltd., AMAG Pharmaceuticals, Rockwell Medical and Akebia Therapeutics and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Renal Anemia Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Renal Anemia Treatment Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Renal Anemia Treatment Market Segment Percentages, by Type, 2021 (%)
Iron Supplements
Erythrocyte Stimulating Agents
Global Renal Anemia Treatment Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Renal Anemia Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital
Pharmacy
Research Institute
Other
Global Renal Anemia Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Renal Anemia Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Renal Anemia Treatment revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Renal Anemia Treatment revenues share in global market, 2021 (%)
Key companies Renal Anemia Treatment sales in global market, 2017-2022 (Estimated), (MT)
Key companies Renal Anemia Treatment sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen Inc.
F. Hoffmann-La Roche Ltd
Pfizer Inc.
Novartis AG
Johnson & Johnson Services Inc.
Teva Pharmaceutical Industries Ltd.
AMAG Pharmaceuticals
Rockwell Medical
Akebia Therapeutics
Vifor Pharma Management Ltd.